192 related articles for article (PubMed ID: 36483902)
1. An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review.
Fidahussain AA; Abid A; Paracha AA; Jeevan VE; Rueve J; Engelhardt M; Schrock C; Ghani S; Nair HK
Cureus; 2022 Nov; 14(11):e31154. PubMed ID: 36483902
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report.
Deac S; Stana MM; Havasi AD; Cainap C; Popita AR; Bordeianu AM; Cainap S; Bota M; Bochis OV
Gynecol Oncol Rep; 2021 Feb; 35():100695. PubMed ID: 33490355
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
4. The early diagnoses and treatment of anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a patient with breast cancer: a case report.
Wang W; Liu H; Liu Y; Liu Q
Transl Cancer Res; 2022 May; 11(5):1434-1439. PubMed ID: 35706816
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
6. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
Liu S; Tunkel R; Lachmann E; Nagler W
Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
[TBL] [Abstract][Full Text] [Related]
10. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
Sahoo D; Dey A; Dash A; Dash A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
[TBL] [Abstract][Full Text] [Related]
11. Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J; Albarrán-Fernández V; González-Campo L; Olmedo-García ME; Corral de la Fuente E; Corral-Corral I; Carrasco Á; Alonso-Gordoa T; Molina-Cerrillo J; Lage-Alfranca Y; Gómez-Rueda A; Garrido P
Transl Lung Cancer Res; 2022 Jul; 11(7):1497-1502. PubMed ID: 35958343
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG; Root JC
Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
[TBL] [Abstract][Full Text] [Related]
13. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Cerebellar Degeneration Leading to an Early Diagnosis of Peritoneal Serous Papillary Carcinoma.
Yasuda T; Shimizu J; Miyagawa T; Tsutsumi Y; Iwatsubo T; Tsuji S
Intern Med; 2024 Mar; ():. PubMed ID: 38432969
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
Cui D; Xu L; Li WY; Qian WD
Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1359-62. PubMed ID: 16801349
[TBL] [Abstract][Full Text] [Related]
18. Update on Paraneoplastic Cerebellar Degeneration.
Loehrer PA; Zieger L; Simon OJ
Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827413
[No Abstract] [Full Text] [Related]
19. Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject.
Ng YR; Ho CD; Ng WL; Tan SM
Surg Case Rep; 2015; 1(1):59. PubMed ID: 26366356
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
